Oxford Cannabinoid Technologies (OCTP) News Today GBX 0.12 -0.01 (-4.17%) (As of 06/5/2024) Add Compare Share Share Headlines Stock AnalysisChartInsider Trades All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street TipRanks The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 February 2022 January 2022 December 2021 Time Period Oxford Cannabinoid Technologies (LON:OCTP) Shares Down 4.2% - Should You Sell?November 16, 2024 | americanbankingnews.comSnoop Dogg-Backed Cannabis Biotech Joins Forces With Former Google Experts To Boost AI Drug DiscoveryNovember 6, 2024 | benzinga.comOxford Cann Share ChatMay 24, 2024 | lse.co.ukOxford Cannabinoid to Delist from London Stock ExchangeMay 8, 2024 | marketwatch.comA bad trip: Oxford Cannabinoid to delist from ‘turbulent’ London marketsMay 8, 2024 | msn.comOxford Cannabinoid Technologies Holdings PLCOctober 15, 2023 | wsj.comWeed In Europe: Medical Marijuana In Ukraine, Albania's Hemp, UK Cannabis Study Lacks DiversityOctober 12, 2023 | benzinga.comOxford Cannabinoid Technologies CEO says objective "absolutely met" in lead asset trialOctober 10, 2023 | finance.yahoo.comOxford Cannabinoid readies for next stage as it safely navigates phase I stduyOctober 10, 2023 | proactiveinvestors.comOxford Cannabinoid readies for next stage as it safely navigates phase I studyOctober 10, 2023 | proactiveinvestors.comOxford Cannabinoid Technologies reports no adverse events in OCT461201 trialSeptember 25, 2023 | finance.yahoo.comOxford Cannabinoid Technologies in a "comfortable position" ahead of Phase 1 results releaseSeptember 1, 2023 | finance.yahoo.comOxford Cannabinoid Technologies hails defining year as...Oxford Cannabinoid Technologies hails defining year as clinical...August 31, 2023 | proactiveinvestors.comOxford Cannabinoid Technologies "officially on the way" after first dosingJuly 28, 2023 | finance.yahoo.comOxford Cannabinoid Technologies takes pain drug into phase I; appoints leading pain expertJuly 27, 2023 | proactiveinvestors.comOxford Cannabinoid Technologies announces "potential breakthrough" in field of oncologyJuly 24, 2023 | finance.yahoo.comOxford Cannabinoid appoints chief medical officerJune 8, 2023 | proactiveinvestors.comOxford Cannabinoid Technologies reaches milestone with phase 1 trial approval for pain relief drugMay 18, 2023 | proactiveinvestors.comOxford Cannabinoid rise continues as first clincial trial gets startedMay 17, 2023 | proactiveinvestors.comOxford Cannabinoid Technologies confirms CEO appointment, licence renewal and clinical progressApril 13, 2023 | proactiveinvestors.comOxford Cannabinoid Technologies confirms Sowemimo-Coker as permanent CEOApril 12, 2023 | proactiveinvestors.comOxford Cannabinoid Technologies shares spike on CEO appointment and licence renewalApril 12, 2023 | proactiveinvestors.comOxford Cannabinoid Technologies Holdings Plc (OCTP.L)March 1, 2023 | finance.yahoo.comOxford Cannabinoid Technologies Holdings PLC (OCTP)February 10, 2023 | uk.investing.comOxford Cannabinoid interim loss nearly doubles as research costs surgeJanuary 25, 2023 | lse.co.ukProactive's John Savin publishes fresh research note on Oxford Cannabinoid TechnologiesJanuary 24, 2023 | proactiveinvestors.comOxford Cannabinoid Technologies with "lots to look forward to" after interimsJanuary 23, 2023 | proactiveinvestors.comOxford Cannabinoid Technologies "proceeding forward as planned" after review meetingJanuary 12, 2023 | proactiveinvestors.comOxford Cannabinoid Technologies "ready to go" after phase 1 trial submissionJanuary 6, 2023 | proactiveinvestors.comOxford Cannabinoid Technologies hails 'milestone' as it submits Phase I trial application for lead programmeJanuary 5, 2023 | proactiveinvestors.comOxford Cannabinoid Technologies nearly ready for new phase 1 trialNovember 14, 2022 | proactiveinvestors.comData from pre-clinical study of OCT461201 shows positive resultsNovember 14, 2022 | finance.yahoo.com Get Oxford Cannabinoid Technologies News Delivered to You Automatically Sign up to receive the latest news and ratings for OCTP and its competitors with MarketBeat's FREE daily newsletter. Email Address The #1 ETF for monthly income (Ad)We just found the #1 ETF for monthly income. This outlier is paying a huge 22% dividend... And you could start collecting it if you act by December 19th. Click here to get the full story >> OCTP Media Mentions By Week OCTP Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. OCTP News Sentiment▼0.750.49▲Average Medical News Sentiment OCTP News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. OCTP Articles This Week▼10▲OCTP Articles Average Week Get Oxford Cannabinoid Technologies News Delivered to You Automatically Sign up to receive the latest news and ratings for OCTP and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies Fusion Antibodies News Evgen Pharma News Destiny Pharma News ValiRx News Physiomics News Oxford Nanopore Technologies News Genus News Oxford Biomedica News PureTech Health News Bioventix News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (LON:OCTP) was last updated on 11/22/2024 by MarketBeat.com Staff From Our Partners“Amazon Coin” set to outperform BitcoinChris Rowe – the man who recommended Amazon in 1998… Bitcoin and Ethereum in 2017… And has spotted 44 diffe...True Market Insiders | SponsoredTrump won. Buy this coin now.Juan Villaverde called the top and bottom of every crypto bull market since 2012. He believes Bitcoin will ...Weiss Ratings | SponsoredBuffett’s Selling Out: Is Your 401(k) About to Get Wiped Out?Let me share something important with you. Just a few weeks ago, Warren Buffett unloaded $932 million worth of...Golden Crest | SponsoredA “Thank You Gift” From Pres. Trump - GeniusTrump quietly left open an "off the books" wealth-protection loophole hidden in the 6,871 pages of the IRS Tax...Colonial Metals | Sponsored[625,000% Gain] – Are You Ready for the Next Altcoin Boom?All of our key indicators are flashing the same signal: an altcoin season is fast approaching. And if you k...Crypto Swap Profits | Sponsored“Sleeping Giant” Crypto Set to Explode…What if I told you there's a crypto that could make Bitcoin look like small change? We're looking at potent...Crypto 101 Media | SponsoredThis company will win the AI race Rome wasn’t built in a day… But there is another lesser-known type of keystone, one that plays an equally c...Porter & Company | Sponsored⭕ [URGENT] Buy Alert just triggeredMy absolute favorite stock just hit a critical "buy now" trigger price.Behind the Markets | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Oxford Cannabinoid Technologies Holdings Plc Please log in to your account or sign up in order to add this asset to your watchlist. Share Oxford Cannabinoid Technologies With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
